Neurology trial tests low-dose lithium for MCI and Alzheimer risk; results miss primary end points but hint at slower verbal memory decline.
Amjad Shono, PA-C
Advertisement
Articles by Amjad Shono, PA-C
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves XFG-Adapted COVID-19 Vaccine, mRNA for the 2026-2027 Season
2
Beyond the Transplant Center: IV Therapy in the Community
3
Incorporating Patient-Reported Symptoms into Treatment Plans
4
Building the pharmacy of the future — trust, loyalty, and growth
5